1. Pattar SK, Greenway SC. Circulating nucleic acids as biomarkers for allograft injury after solid organ transplantation: current state-of-theart. Transpl Res Risk Manag 2019: 17-27. [
DOI]
2. Sawinski D, Goral S. BK virus infection: an update on diagnosis and treatment. Nephrol Dial Transplant 2015; 30(2): 209-17. [
DOI]
3. Afshari A, Yaghobi R, Rezaei G. Interregulatory role of microRNAs in interaction between viruses and stem cells. World J Stem Cells 2021; 13(8): 985-1004. [
DOI]
4. Soltaninejad E, Nicknam MH, Nafar M, et al. Altered expression of microRNAs following chronic allograft dysfunction with interstitial fibrosis and tubular atrophy. Iran J Allergy Asthma Immunol 2015; 14(6): 615-23. [
PubMed]
5. Golsha R, Gooran Orimi A, Khodabakhshi B, et al. Prevalence of infectious diseases in patients with end stage renal disease in Gorgan City in Iran. Tehran Univ Med J 2020; 78(4): 233-8. (Persian) [
Article]
6. Li JY, McNicholas K, Yong TY, et al. BK virus encoded microRNAs are present in blood of renal transplant recipients with BK viral nephropathy. Am J Transplant 2014; 14(5): 1183-90. [
DOI]
7. Haddad G, Kölling M, Lorenzen JM. The hypoxic kidney: pathogenesis and noncoding RNA-based therapeutic strategies. Swiss Med Wkly 2019; 149: w14703. [
DOI]
8. Gámez-Valero A, Lozano-Ramos SI, Bancu I, et al. Urinary extracellular vesicles as source of biomarkers in kidney diseases. Front Immunol 2015; 6: 6. [
DOI]
9. O'Brien J, Hayder H, Zayed Y, et al. Overview of microRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol (Lausanne) 2018; 9: 402. [
DOI]
10. Zeng G, Wang Z, Huang Y, et al. Cellular and viral miRNA expression in polyomavirus BK infection. Transpl Infect Dis 2019; 21(5): e13159. [
DOI]
11. Yaghobi R, Afshari A, Roozbeh J. Host and viral RNA dysregulation during BK polyomavirus infection in kidney transplant recipients. Wiley Interdiscip Rev RNA 2023; 14(4): e1769. [
DOI]
12. Kariminik A, Yaghobi R, Dabiri S. Innate immunity and BK virus: prospective strategies. Viral Immunol 2016; 29(2): 74-82. [
DOI]
13. Foroudi MR, Yaghobi R, Afshari A, et al. The effect of the BK polyomavirus large T antigen on the function and maturity of the CD4+ T cell subsets in kidney transplant recipients. Transpl Immunol 2023; 80: 101884. [
DOI]
14. Foroudi MR, Yaghobi R, Afshari A, et al. The effect of BK polyomavirus large T antigen on CD4 and CD8 T cells in kidney transplant recipients. Transpl Immunol 2022; 74: 101655. [
DOI]
15. Sun IO, Lerman LO. Urinary microRNA in kidney disease: Utility and roles. Am J Physiol Renal Physiol 2019; 316(5): F785-F793. [
DOI]
16. Noshadi N, Yaghoubi R, Afshari A, et al. Impaired CD4+ Cytotoxic T Lymphocyte Activity in Polyomavirus BK Infected Kidney Transplant Recipients. Iran J Allergy Asthma Immunol 2023; 22(4): 379-389. [
DOI]
17. Zou W, Imperiale MJ. Biology of polyomavirus miRNA. Front Microbiol 2021; 12: 662892. [
DOI]
18. Bauman Y, Nachmani D, Vitenshtein A, et al. An identical miRNA of the human JC and BK polyoma viruses targets the stress-induced ligand ULBP3 to escape immune elimination. Cell Host Microbe 2011; 9(2): 93-102. [
DOI]
19. Huang Y, Zeng G, Randhawa PS. Detection of BKV encoded mature MicroRNAs in kidney transplant patients: Clinical and biologic insights. J Clin Virol 2019; 119: 6-10. [
DOI]
20. Wilflingseder J, Regele H, Perco P, et al. miRNA profiling discriminates types of rejection and injury in human renal allografts. Transplantation 2013; 95(6): 835-41. [
DOI]
21. Li J, Yue S, Fang J, et al. MicroRNA-10a/b inhibit TGF-β/Smad-induced renal fibrosis by targeting TGF-β receptor 1 in diabetic kidney disease. Mol Ther Nucleic Acids 2022; 28: 488-99. [
DOI]
22. Lu TX, Rothenberg ME. MicroRNA. J Allergy Clin Immunol 2018; 141(4): 1202-7. [
DOI]
23. Song K, Jiang Y, Zhao Y, et al. Members of the miR‑30 family inhibit the epithelial‑to‑mesenchymal transition of non‑small‑cell lung cancer cells by suppressing XB130 expression levels. Oncol Lett 2020; 20(4): 68. [
DOI]
24. Mahmudpour M, Nabipour I, Esmailie AH, at al. A Case of Systemic Lupus Erythematosus with Renal Failure Following the Administration of Sinopharm COVID -19 Vaccine. Iran South Med J 2022; 25(3): 277- 284. (Persian) [
DOI]